Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Exp Parasitol ; 116(3): 296-301, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17286971

RESUMO

This study aimed to evaluate whether experimental Chagas disease in acute phase under benznidazole therapy can cause DNA damage in peripheral blood, liver, heart, and spleen cells or induce nitric oxide synthesis in spleen cells. Twenty Balb/c mice were distributed into four groups: control (non-infected animals); Trypanosoma cruzi infected; T. cruzi infected and submitted to benznidazole therapy; and only treated with benznidazole. The results obtained with the single cell gel (comet) assay showed that T. cruzi was able induce DNA damage in heart cells of both benznidazole treated or untreated infected mice. Similarly, T. cruzi infected animals showed an increase of DNA lesions in spleen cells. Regarding nitric oxide synthesis, statistically significant differences (p<0.05) were observed in all experimental groups compared to negative control, the strongest effect observed in the T. cruzi infected group. Taken together, these results indicate that T. cruzi may increase the level of DNA damage in mice heart and spleen cells. Probably, nitric oxide plays an important role in DNA damaging whereas benznidazole was able to minimize induced T. cruzi genotoxic effects in spleen cells.


Assuntos
Doença de Chagas/metabolismo , Dano ao DNA , Óxido Nítrico/biossíntese , Trypanosoma cruzi/patogenicidade , Animais , Células Sanguíneas/patologia , Doença de Chagas/complicações , Doença de Chagas/tratamento farmacológico , Doença de Chagas/genética , Fígado/citologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Miocárdio/citologia , Neoplasias/etiologia , Nitroimidazóis/uso terapêutico , Distribuição Aleatória , Baço/citologia , Baço/metabolismo , Tripanossomicidas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA